ROSG
Rosetta Genomics Ltd.
ROSG
ROSG
Delisted
ROSG was delisted on the 21st of May, 2018.
10 hedge funds and large institutions have $280K invested in Rosetta Genomics Ltd. in 2017 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
10
Holders Change
+1
Holders Change %
+11.11%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$209K |
| 2 |
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$20K |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$3K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $209K | +$99.9K | +179,907 | +92% |
|
|
VF
2
Virtu Financial
New York
| $43K | -$2.54K | -4,533 | -6% |
|
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $20K | +$20K | +36,171 | New |
|
|
HCM
4
Highlander Capital Management
Short Hills,
New Jersey
| $5K | -$7.02K | -12,136 | -58% |
|
|
5
UBS Group
Zurich,
Switzerland
| $3K | +$493 | +904 | +20% |
|
|
SM
6
Sabby Management
Miami Beach,
Florida
| – | -$149K | -141,741 | Closed |
|